Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tekturna Launch Anticipated “Very Quickly” Following Approval

Jan 10 2007

• By Jessica Merrill

Related Content

Speedel Could Market Blood Clot Candidate On Its Own

Aug 16 2006

FDA Review Of Novartis’ Tekturna Set Back Three Months

Dec 14 2006

Fate Of Speedel’s Diabetic Nephropathy Drug May Be Clearer Mid-Year 2007

Dec 19 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window